Loomis, Sayles & Company
EHC icon

Loomis, Sayles & Company’s Encompass Health EHC Stock Holding History

Loomis, Sayles & Company’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.01M Buy
+72,488
New +$7.43M 0.01% 392
2022
Q4 		– Sell
-21,505
Closed -$973K – 893
2022
Q3 		$973K Sell
21,505
-299,466
-93% -$15M ﹤0.01% 415
2022
Q2 		$14.3M Buy
320,971
+37,360
+13% +$1.92M 0.03% 310
2022
Q1 		$16M Buy
283,611
+69,965
+33% +$3.65M 0.02% 319
2021
Q4 		$11.1M Sell
213,646
-96,325
-31% -$4.97M 0.01% 372
2021
Q3 		$18.5M Buy
309,971
+8,818
+3% +$555K 0.02% 313
2021
Q2 		$18.7M Buy
301,153
+11,834
+4% +$789K 0.02% 313
2021
Q1 		$18.9M Buy
289,319
+44,840
+18% +$2.92M 0.02% 292
2020
Q4 		$16.1M Buy
244,479
+29,056
+13% +$1.71M 0.02% 288
2020
Q3 		$11.1M Sell
215,423
-2,258
-1% -$116K 0.02% 305
2020
Q2 		$10.7M Buy
217,681
+16,783
+8% +$906K 0.02% 299
2020
Q1 		$10.2M Buy
+200,898
New +$11.6M 0.02% 278
2019
Q2 		– Sell
-46,934
Closed -$2.18M – 621
2019
Q1 		$2.18M Buy
46,934
+46,460
+9,802% +$2.35M ﹤0.01% 502
2018
Q4 		$23K Hold
474
– – ﹤0.01% 659
2018
Q3 		$29K Sell
474
-254
-35% -$15.4K ﹤0.01% 685
2018
Q2 		$39K Sell
728
-175
-19% -$8.75K ﹤0.01% 636
2018
Q1 		$41K Sell
903
-75
-8% -$3.21K ﹤0.01% 621
2017
Q4 		$38K Buy
978
+206
+27% +$7.83K ﹤0.01% 640
2017
Q3 		$28K Buy
772
+112
+17% +$3.99K ﹤0.01% 702
2017
Q2 		$25K Sell
660
-271
-29% -$9.92K ﹤0.01% 727
2017
Q1 		$32K Buy
931
+85
+10% +$2.79K ﹤0.01% 685
2016
Q4 		$28K Sell
846
-504
-37% -$16.4K ﹤0.01% 727
2016
Q3 		$44K Buy
1,350
+140
+12% +$4.54K ﹤0.01% 670
2016
Q2 		$37K Buy
1,210
+5
+0.4% +$156 ﹤0.01% 665
2016
Q1 		$36K Sell
1,205
-2,136
-64% -$59K ﹤0.01% 685
2015
Q4 		$93K Hold
3,341
– – ﹤0.01% 719
2015
Q3 		$102K Buy
3,341
+2,941
+735% +$102K ﹤0.01% 742
2015
Q2 		$15K Buy
+400
New +$14.3K ﹤0.01% 772

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Loomis, Sayles & Company's EHC Position: Q1 2026 in Review

Loomis, Sayles & Company opened a new position in Encompass Health (EHC) in Q1 2026: 72,488 shares worth $7.01M. The stake represents 0.01% of the portfolio and ranks #392 among its holdings. This is a return to the name: Loomis, Sayles & Company previously reported a position in EHC as recently as Q3 2022.

Loomis, Sayles & Company first reported a position in EHC in Q2 2015 and has held it in 28 quarters since. The position peaked at $18.9M in Q1 2021. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Loomis, Sayles & Company held 72,488 shares of Encompass Health worth $7.01M as of Q1 2026.
  • Encompass Health was a new Loomis, Sayles & Company position in Q1 2026.
  • Encompass Health made up 0.01% of Loomis, Sayles & Company's portfolio in Q1 2026, its #392 holding.
  • Loomis, Sayles & Company first reported a position in Encompass Health in Q2 2015 and has held it in 28 quarters since.
  • Loomis, Sayles & Company's Encompass Health position peaked at $18.9M in Q1 2021.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.